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Stable expression of Gal/GalNAc lectin of Entamoeba 
histolytica in transgenic chloroplasts and immunogenicity 
in mice towards vaccine development for amoebiasis
Seethamahalakshmi Chebolu and Henry Daniell*
Department of Molecular Biology and Microbiology, University of Central Florida, Biomolecular Science, Bldg. #20, Room 336, Orlando, FL 32816-2364, USA 
Summary
Chloroplast genetic engineering offers several advantages, including high levels of 
transgene expression, transgene containment via maternal inheritance and multigene 
engineering in a single transformation event. Entamoeba histolytica infects 50 million 
people, causing about 100 000 deaths annually, but there is no approved vaccine against 
this pathogen. LecA, a potential target for blocking amoebiasis, was expressed for the first 
time in transgenic plants. Stable transgene integration into chloroplast genomes and 
homoplasmy were confirmed by polymerase chain reaction and Southern blot analyses. 
LecA expression was evaluated by Western blots and quantified by enzyme-linked 
immunosorbent assay (up to 6.3% of total soluble protein or 2.3 mg LecA/g leaf tissue). 
Subcutaneous immunization of mice with crude extract of transgenic leaves resulted in 
higher immunoglobulin G titres (up to 1 : 10 000) than in previous reports. An average yield 
of 24 mg of LecA per plant should produce 29 million doses of vaccine antigen per acre of 
transgenic plants. Such high levels of expression and immunogenicity should facilitate the 
development of a less expensive amoebiasis vaccine.
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Introduction
Amoebiasis caused by Entamoeba histolytica, an enteric pro-
tozoan parasite, ranks only second to malaria as a protozoan
cause of death. The World Health Organization estimates
that there are about 50 million cases of colitis and liver
abscess annually and about 100 000 deaths each year from
E. histolytica infection (Dodson et al., 1998; Huston and
Petri, 1998; Petri et al., 2002). This infection occurs through-
out the world, but predominantly in the developing countries
of Central and South America, Africa and Asia.
Amoebic adherence and contact-dependent cytolysis of
target cells are mediated by amoebic galactose/N-acetyl-D-
galactosamine (Gal/GalNAc)-inhibitable adhesin (Mann and
Lockhart, 1998). The Gal/GalNAc lectin is a heterodimer
with disulphide-linked heavy (170-kDa) and light (35/31-kDa)
subunits, which are non-covalently associated with an
intermediate subunit of 150 kDa (Huston and Petri, 1998;
Mann and Lockhart, 1998; Mann, 2002; Petri et al., 2002).
The light subunit is encoded by multiple genes encoding
isoforms with different post-translational modifications.
The 35-kDa isoform is highly glycosylated and lacks the
acylglycosylphosphatidylinositol (GPI) anchor present in the
31-kDa isoform (McCoy et al., 1993; Ramakrishnan et al., 2000).
The carbohydrate recognition domain (CRD) was identified
in the heavy subunit of the Gal/GalNAc lectin, and it has been
demonstrated that an adherence-inhibitory antibody response
against this domain protects against amoebic liver abscess in
an animal model (Dodson et al., 1998). Preliminary studies
have shown that the recombinant fragments of the cysteine-
rich region of lectin (termed ‘LecA’) containing the CRD of
Gal/GalNAc lectin confer protection against amoebiasis
(Mann et al., 1993; Houpt et al., 2004).
Chloroplast genetic engineering offers several unique
advantages, including high levels of transgene expression,
multigene engineering in a single transformation event,
appropriate post-translational modifications with the excep-
tion of glycosylation, low cost of production and maternal
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inheritance of the transgenes or containment via cytoplasmic
male sterility (Daniell, 2002; Grevich and Daniell, 2005; Quesada-
Vargas et al., 2005; Ruiz and Daniell, 2005). In addition, some
of the challenges encountered in nuclear transgene expres-
sion, including the position effect (Daniell et al., 2001; Grevich
and Daniell, 2005) and gene silencing at both the level of
transcription (Lee et al., 2003; Dhingra et al., 2004) and
translation (DeCosa et al., 2001), can be overcome in trans-
genic chloroplasts.
Tobacco is an ideal choice because of its ease of genetic
manipulation, large biomass, prolific seed production and
self-pollination (this provides the advantages of maternal
inheritance and containment of the transgene via the
chloroplast genome) (Watson et al., 2004; Koya et al., 2005).
Vaccine antigens that have already been expressed via the
chloroplast genome include the cholera toxin B-subunit
(Daniell et al., 2001), the F1-V fusion antigen for plague
(Singleton, 2003), the 2L21 peptide from the canine parvovirus
(Molina et al., 2004, 2005), anthrax protective antigen
(Watson et al., 2004; Koya et al., 2005), the C-terminus of
Clostridium tetani (Tregoning et al., 2003), rotavirus VP6
protein (Birch-Machin et al., 2004) and NS3 protein as vaccine
antigen for hepatitis C (Bhati, 2005).
Using the chloroplast transformation approach, several
proteins have been expressed, including human elastin-
derived polymers for various biomedical applications
(Guda et al., 2000; Daniell et al., 2005a), magainin, a broad-
spectrum topical agent, systemic antibiotic, wound-healing
stimulant and potential anticancer agent (DeGray et al.,
2001), human blood proteins, including human serum
albumin (Fernandez-San Millan et al., 2003), interferon and
insulin-like growth factor (Daniell et al., 2004a), human
somatotropin (Staub et al., 2000) and interferon–β-glucuro-
nidase (GUS) fusion proteins (Leelavathi and Reddy, 2003).
In addition, the transformation of plastids in non-green tissue
in cotton, soybean and carrot has recently been achieved
(Dufourmantel et al., 2004; Kumar et al., 2004a; Daniell
et al., 2005b). In particular, plastid transformation in carrot
and lettuce (Kumar et al., 2004a,b; Lelivelt et al., 2005;
Kanamoto et al., 2006) opens the door for the oral delivery
of vaccine antigens.
The aforementioned observations suggest that chloroplast
transformation may be an ideal system for the expression of
vaccine antigens and other therapeutic proteins in large
quantities. In this study, we report the expression of LecA, a
surface antigen of E. histolytica, in transgenic chloroplasts,
and the evaluation of the immunogenicity of the vaccine anti-
gen in mice. This is the first report of LecA expression in any
cellular compartment of transgenic plants.
Results
Construction of vectors
The pLD-SC vector (Figure 1) was derived from the universal
transformation vector pLD-CtV (Daniell et al., 1998). The
pLD-SC chloroplast transformation vector, containing the aadA
gene, LecA coding region and 3′ psbA, integrates the trans-
gene cassette into the trnI–trnA region of the chloroplast
genome via homologous recombination. Integration of the
transgene into one inverted repeat region facilitates integra-
tion into another inverted repeat via the copy correction
mechanism. The T7 bacteriophage gene10 5′ untranslated
region (UTR) containing the ribosome binding site (rbs)
enhances the translation of LecA, and the psbA 3′ UTR present
in the transgene cassette confers transcript stability. The
chimeric, aminoglycoside-3′-adenlyl transferase (aadA) gene,
conferring resistance to spectinomycin, was used as a selectable
marker; its expression is driven by the 16S (Prrn) promoter
(Svab and Maliga, 1993; Daniell, 1997; Kumar and Daniell, 2004).
Polymerase chain reaction (PCR) confirmation of 
transgene integration in chloroplasts
After the bombardment of tobacco leaves with pLD-SC plasmid-
coated gold particles, about five shoots/plate appeared after
a period of 5–6 weeks. True chloroplast transformants were
distinguished from nuclear transformants and mutants by
PCR. Two primers, 3P and 3M, were used to test for the chlo-
roplast integration of transgenes (Daniell, 1997; Daniell et al.,
2004b; Kumar and Daniell, 2004). The primer 3P landed on
the native chloroplast DNA within the 16S rDNA gene and
the primer 3M landed on the aadA gene, as shown in
Figure 2a, thereby eliminating nuclear transformants and
mutants. The primers 3P and 3M, on chloroplast integration
of the transgene, yielded a 1.65-kb product as shown in
Figure 2b.
Figure 1 Schematic representation of pLD-SC. The pLD-SC tobacco 
transformation vector contains the trnI and trnA genes as flanking 
sequences for homologous recombination. The constitutive 16S rRNA 
promoter regulates the expression of the aadA gene (aminoglycoside-3′-
adenylyltransferase) that confers resistance to spectinomycin–
streptomycin and the gene10-LecA gene encoding the Entamoeba 
histolytica lectin antigen. Upstream of trnA, the vector contains the 3′ 
untranslated region (UTR), which is a transcript stabilizer, derived from 
the chloroplast psbA gene.
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The integration of the aadA gene, gene10-LecA gene and
3′ psbA cassette was confirmed using the 5P and 2M primer
pair for PCR analysis. The 5P and 2M primers annealed to the
internal regions of the aadA gene and the trnA gene, respec-
tively, as shown in Figure 2a. The product size of the positive
clone was 3.3 kb for LecA; the mutants and control should
not show any product. Figure 2c shows the result of the 5P/
2M PCR analysis. As spectinomycin was used to select for the
true chloroplast transformants, any mutants obtained were
spontaneous. After PCR analysis using both primer pairs, the
transgenic plants were subsequently transferred through
different rounds of selection to obtain a mature plant and to
reach homoplasmy (containing only transformed chloroplasts).
Evaluation of homoplasmy
The plants that tested positive for PCR analysis were moved
through three rounds of selection, and were then tested by
Southern blot analysis for site-specific integration of the
transgene and homoplasmy. DNA of the fully regenerated
clones growing in jars (third selection) was extracted and
used for Southern blot analysis. A flanking sequence probe of
0.81 kb in size allowed the detection of the site-specific inte-
gration of the gene cassette into the chloroplast genome
(Figure 3a). Figure 3b shows the HincII sites present outside
the recombination region used for the restriction digestion of
the plant DNA. The transformed chloroplast genome digested
with HincII produced fragments of 6.0 and 2.0 kb for pLD-SC
(Figure 3c), whereas the untransformed chloroplast genome
that had been digested with HincII generated a 5.0-kb fragment.
The flanking sequence probe also indicated whether homo-
plasmy of the chloroplast genome had been achieved through
three rounds of selection. If homoplasmy (containing only
transformed chloroplasts) had not been achieved, hetero-
plasmy (containing both transformed and untransformed
chloroplasts) could result in changes in the relative ratios of
the two genomes on cell division. The plants expressing LecA
showed homoplasmy, as no hybridizing wild-type fragment
was seen in transgenic lines. The gene-specific probe showed
transgene integration, resulting in a fragment of 6 kb, as
illustrated in Figure 3d.
Expression of LecA in transgenic chloroplasts
Goat anti-LecA polyclonal antibodies were used to detect the
64-kDa protein. The wild-type plant (‘Petit havana’) did not
show any bands, indicating that the anti-LecA antibodies did
not cross-react with any other proteins in the crude extract.
The T1 generation plants showed good levels of expression
(Figure 4). Each of the lanes contained around 1.5 µg of the
Figure 2 Polymerase chain reaction (PCR) analysis of wild-type and putative transformants of pLD-gene10-LecA. (a) Primers land within the native 
chloroplast genome (3P) or the aadA gene (3M) to yield a 1.65-kb product, and 5P/2M primers yield a 3.3-kb product. (b) Lane 1, 1-kb plus DNA ladder; 
lane 2, positive control (interferon clone); lanes 3–7, transgenic lines pLD-gene10-LecA (2, 6, 8*, 14, 17); lane 8, negative control (wild-type). 
(c) Lane 1, 1-kb plus DNA ladder; lane 2, positive control (pLD-gene10-LecA plasmid); lanes 3–7, transgenic lines pLD-gene10-LecA (2, 6, 8*, 14, 17); 
lane 8, negative control (wild-type).
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LecA protein detected by the LecA antibodies. The lower
bands seen are probably cleaved LecA protein and the higher
bands are probably LecA protein aggregates.
Quantification of transgenic plant-derived LecA 
protein
Different dilutions of purified LecA were used to obtain a
standard curve. Goat polyclonal antibodies against LecA were
used as the primary antibody, and the secondary antibody
was peroxidase-conjugated rabbit anti-goat immunoglobulin
G (IgG). The percentage of LecA, expressed as a percentage
of total soluble protein (TSP), was calculated using the Brad-
ford assay, i.e. the LecA percentage was inversely propor-
tional to the TSP values. LecA expression reached maximum
levels of 6.3% of TSP in old leaves, 2.6% of TSP in young
leaves and 5.2% of TSP in mature leaves. Maximum LecA
expression was observed in old leaves (Figure 5a). On the
basis of the fresh weight calculations, the amounts of LecA
obtained from young, mature and old leaves were 0.67, 2.32
and 1 mg per leaf, respectively (Figure 5b). Figure 5c shows
the amount of LecA (µg) per milligram of leaf.
Evaluation of immunogenicity
Having confirmed the expression of lectin in transgenic
plants, we tested the ability of plant-derived lectin to be func-
tional in vivo. For this, mice were immunized with crude
extracts of the lectin-expressing plant. Mice groups immunized
with crude extracts of the lectin-expressing plant together
with adjuvant showed immunization titres up to 1 : 10 000,
and mice groups immunized with crude extracts of the lectin-
expressing plant with no adjuvant showed immunization
titres up to 1 : 4000 (Figure 6).
Discussion
The pLD-SC vector was derived from the universal transfor-
mation vector pLD-CtV. The pLD-SC transgene cassette was
Figure 3 Southern blot analysis of pLD-gene10-LecA. Schematic diagram of the products expected from digestion of wild-type untransformed plants 
(a) and plants transformed with pLD-SC (b). (c) Southern blot with the flanking sequence probe of pLD-gene10-LecA transgenic plants showing 
homoplasmy. Lane 1, 1-kb plus DNA ladder; lane 2, wild-type; lanes 3–6, pLD-SC transgenic lines (8*, 17). (d) LecA gene-specific probe showing the 
presence of LecA in the transgenic plants. Lane 1, 1-kb plus DNA ladder; lane 2, wild-type; lanes 3–6, pLD-SC transgenic lines (8*, 17).
Figure 4 Immunoblot analysis of crude plant extracts expressing LecA. 
Lane 1, T1 generation transgenic plant (28 µg crude plant extract loaded); 
lanes 2 and 4, T0 generation transgenic plant (28 µg crude plant extract 
loaded); lane 6, wild-type; lane 7, standard protein (1 µg); lane 9, marker; 
lanes 3, 5, 8, 10, empty.
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integrated into the trnI–trnA region of the chloroplast
genome via homologous recombination. Expression of the
LecA recombinant protein in the chloroplast depends on
several factors. First, the pLD-SC vector was designed to
integrate into the inverted repeat region of the chloroplast
genome via homologous recombination. The copy number of
the transgene is thus doubled when integrated at this site.
The increased copy number leads to increased transcript
levels, resulting in higher protein accumulation (Grevich and
Daniell, 2005; Quesada-Vargas et al., 2005). Second, the T7
bacteriophage gene10 5′ UTR containing the rbs and psbA-
3′ UTR has been successfully used to enhance the translation
of foreign proteins (Guda et al., 2000; Staub et al., 2000;
Dhingra et al., 2004). Third, homoplasmy of the transgene is
a condition in which all of the chloroplast genomes contain
the transgene cassette. There are 100–1000 chloroplasts per
cell and 100–1000 chloroplast genomes per chloroplast
(Daniell et al., 2005b); for optimal production of the recom-
binant protein and transgene stability, it is essential that
homoplasmy be achieved through several rounds of selection
on medium containing spectinomycin. Fourth, expression
can depend on the source of the gene and its relative AT/GC
content. The prokaryotic-like chloroplast favours AT-rich
sequences, which reflects the respective tRNA abundance.
Therefore, the LecA gene having 67% AT was expected to
express well in the chloroplast, similar to human serum albu-
min (66% AT). High-level expression of several other human
proteins, including human somatotropin, interferon-α2b,
interferon-α and insulin-like growth factor, shows that eukaryotic
genes can be expressed well in transgenic chloroplasts (Staub
et al., 2000; Fernandez-San Millan et al., 2003; Leelavathi
and Reddy, 2003; Daniell et al., 2005a). Thus, genetic en-
gineering of the chloroplast genome to express LecA achieves
high expression levels and offers transgene containment.
PCR analysis was used to distinguish between the chloro-
plast transformants, nuclear transformants and mutants.
Southern blot analysis was utilized to confirm the site-specific
integration of the gene cassette and also to determine homo-
or heteroplasmy. High protein expression levels were obtained
in mature and old leaves of up to 6.3% of TSP, which was
quantified using enzyme-linked immunosorbent assay (ELISA).
The difference in LecA expression levels when calculated on
the basis of the percentage of TSP vs. fresh weight is a result
of the low TSP in old leaves relative to mature leaves. This may
Figure 5 Quantification of LecA expression 
levels in transgenic plants (T0 generation). (a) 
Expression levels, as percentage of total soluble 
protein (TSP), of LecA in young, mature and old 
leaves under regular illumination conditions 
(16 h light and 8 h dark period). (b) Amount of 
LecA (mg) obtained from young, mature and old 
leaves based on the fresh weight. (c) Amount of 
LecA (µg) obtained per milligram of leaf. The 
error bars shown in all figures indicate the 
deviation of the amount of LecA from the mean 
in leaves of different stages, where n = 5 is the 
number of samples used.
Figure 6 Comparison of immune responses in serum samples from mice 
after subcutaneous administration of: (1) leaf crude extract of lectin-
expressing plant together with adjuvant (mean titres of 1 : 9600); (2) leaf 
crude extract of lectin-expressing plant with no adjuvant (mean titres of 
1 : 3600); (3) leaf crude extract of wild-type plant (no immune titres). The 
error bars and statistical analysis represent the deviation of the titres from 
the mean values of the different groups of mice (n = 5).
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possibly be caused by the greater degradation of native
soluble proteins relative to LecA in old leaves. On the basis of
fresh weight, mature leaves showed higher expression levels,
as TSP was not taken into account. A greater number of chlo-
roplasts in mature leaves, their large size and the greater
number of mature leaves per plant contribute to the higher
expression. The correlation between leaf age and expression
levels is very important. Plant cells in young leaves have fewer
chloroplast genomes than those in mature leaves, and this is
reflected in their expression levels of LecA. Plant cells in older
leaves have higher levels of protease activity. Because of the
lower levels of leaf protein in older leaves, it appears that the
LecA expression level is high when calculated on the basis of
TSP, but it is actually lower than that of mature leaves when
calculated on the basis of fresh weight. When evaluating the
total amount of LecA produced in a plant, the age of the leaf
is very important.
An average yield of 24 mg of LecA (Table 1) per plant
should produce 29 million doses of vaccine antigen per acre
of transgenic plants. The dosages per acre were calculated on
the basis of subcutaneous delivery only. In the case of the anthrax
vaccine, the same amount of vaccine antigen (5 µg) is used for
subcutaneous delivery for mice and humans (Koya et al., 2005).
It is possible that, in the amoebiasis vaccine, a higher dosage
may be used for humans. The use of plants for the produc-
tion of vaccine antigens could therefore result in low-cost
vaccine when compared with other expression systems.
Differences in the titre values of the groups of mice receiv-
ing the extract with and without adjuvant were caused by a
depot effect (Audibert, 2003) and by alhydrogel’s non-specific
priming of the immune system. Control mice immunized with
wild-type plant leaf crude extract did not show any immune
response, demonstrating the specificity of the recombinant
lectin-elicited immune response in the case of transgenic plant
crude extracts.
Having confirmed the expression of lectin in transgenic
plants, we tested the ability of plant-derived lectin to be
functional in vivo. Therefore, mice were immunized with
crude extracts of the lectin-expressing plant. Mice groups
immunized with crude extracts of the lectin-expressing plant
together with adjuvant showed immunization titres up to
1 : 10 000, and mice groups immunized with crude extracts
of the lectin-expressing plant with no adjuvant showed
immunization titres up to 1 : 4000 (Figure 6). Previous reports
of vaccination with full-length native lectin antigen in gerbils
through the subcutaneous route yielded titres up to 1 : 1024
(Lotter et al., 2000). Similarly, vaccination in gerbils with a 25-
mer peptide derived from the cysteine-rich region of lectin
yielded IgG titres up to 1 : 200 (Lotter et al., 2000). In this
study, vaccination with crude extracts of LecA transgenic
lines resulted in titres up to 1 : 4000. This represents a 4–20-
fold higher immunogenicity than that obtained with purified
full-length native lectin antigen or peptide derived from the
cysteine-rich region of lectin, although care should be taken
when comparing results between different animal models.
However, the authors would like to stress that the antibody
titres are meaningful. The antibody titres raised against lectin
should confer protective immunity. Lectin helps E. histolytica
to bind to the host cell receptor. The antibody raised against
lectin should prevent E. histolytica from entering the host
tissue by blocking the lectin ligand. Therefore, it can be anti-
cipated that the antibody titres should be protective when
challenged with the pathogen. We could not perform path-
ogen challenge tests because BALB/c mice are not susceptible
to infection with E. histolytica. Our aim of immunization in
this study was to test the ability of plant-derived LecA to elicit
the IgG immune response.
In addition, for pathogen challenge studies, the production
of IgA antibodies would be more effective than the produc-
tion of IgG antibodies, because infection occurs predominantly
in the intestinal mucosa, where secretory IgA plays a predom-
inant role in effectively neutralizing the infection. Therefore,
future investigations should be performed to determine the
immunogenicity of orally administered (in order to elicit the









Amount of LecA (mg) 
per age group
Young 3.2 2.5 0.27 0.67 2.144
Mature 7.8 8 0.29 2.32 18.096
Old 4.5 5 0.20 1 4.05
Total recombinant LecA/plant 24.29
Calculations: 8000 plants are grown, giving 8000 × 24.29 = 194 320 mg. Based on three cuttings per year, the total yield would be 582 960 mg. With an average 
loss of 50% during purification, the net protein yield would be 291 480 mg. The amount of lectin for a single dose of vaccine is 10 µg. At this dose, 291 480 mg 
should give 29 148 000 doses or about 29 million doses. Therefore, 29 million doses may be obtained from one acre of tobacco.
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IgA response) LecA-expressing plant, followed by pathogen
challenge. In this context, the development of plastid trans-
formation systems in lettuce and carrot (Kumar et al., 2004a, b;
Lelivelt et al., 2005; Kanamoto et al., 2006) and the demon-
stration of receptor-mediated oral delivery of foreign pro-
teins expressed in transgenic chloroplasts into the circulatory
system (Limaye et al., 2006) are significant developments in
this field. The development of transgenic carrot or lettuce
expressing LecA should open the door for the oral delivery of
the vaccine and the development of a mucosal immune
response. An ideal vaccine for amoebiasis should induce both
mucosal and systemic protection. If both subcutaneous and
oral delivery proves to be immunoprotective, priming both the
mucosal and systemic systems may prove to be the cheapest
and most effective method of vaccination against any patho-
gen that attacks both the mucosal and systemic systems.
Experimental procedures
Construction of vectors for the transformation of 
tobacco chloroplasts
The plasmid pcDNA 3.1 containing the LecA gene, provided
by Dr Barbara Mann (University of Virginia Health System,
Charlottesville, VA, USA), was used as the template to intro-
duce start and stop codons at the N-terminal and C-terminal
of the LecA gene. The primers used were as follows: forward,
5′-GGAATTGAATTCCATATGTGTGAGAACAGA-3′ reverse, 5′-
AGAATTGCCTCTAGACTATTCTGAAAC-3′. The PCR product
was purified using a PCR purification kit (Qiagen, Valencia, CA)
and was subcloned into the TOPO vector, pCR2.1-LecA. The PCR
product was digested from the pCR2.1-LecA vector with NdeI
and NotI enzymes and subcloned into pBluescript (Stratagene,
La Jolla, CA, USA) containing gene10 T7 bacteriophage UTR,
designated pBS-g10-LecA. The final product containing gene10
and the LecA gene (∼1.8 kb) was digested with HincII and
NotI enzymes and subcloned into the tobacco universal vector
pLD-Ctv (Daniell et al., 1998) between EcoRV and NotI sites.
Bombardment and selection of transgenic shoots
Bombardment and selection of transgenic shoots were
performed as described previously (Svab and Maliga, 1993;
Daniell, 1997; Kumar and Daniell, 2004). A Bio-Rad PDS-1000/
He biolistic device (Bio-Rad, Hercules, CA), which is a particle
delivery system, was used to bombard leaves of Nicotiana
tabacum var. Petit havana. Bombarded leaves, after 2 days of
incubation, were transferred to RMOP (Regeneration Medium
of Plants) medium containing 500 µg/mL of spectinomycin.
After 4–6 weeks, the shoots were transferred to fresh RMOP
plus spectinomycin for the second round of selection. Finally,
after 4 weeks on the second round of selection, the shoots
were transferred to jars containing MSO (Murashige and
Skoog medium with no hormones) medium with 500 µg/mL
spectinomycin.
Confirmation of transgene integration into the 
chloroplast genome
To confirm the transgene cassette integration into the
chloroplast genome, PCR was performed using the primer
pairs 3P (5′-AAAACCCGTCCTCGTTCGGATTGC-3′) and 3M
(5′-CCGCGTTGTTTCATCAAGCCTTACG-3′). To confirm the
integration of the gene of interest, PCR was performed using
the primer pairs 5P (5′-CTGTAGAAGTCACCATTGTTGTGC-3′)
and 2M (5′-GACTGCCCACCTGAGAGCGGACA-3′). Positive
(known transgenic plant DNA sample) and negative (wild-
type Petit havana DNA sample) controls were used to monitor
PCR. The PCR conditions used have been described previ-
ously (Daniell, 1997; Daniell et al., 2004b; Kumar and Daniell,
2004). The PCR product was analysed on 0.8% agarose gel.
Southern blot analysis
Total plant DNA was extracted from transgenic T0 plants and
from untransformed tobacco plants using a Qiagen DNeasy
Plant Mini Kit. Total plant DNA was digested with HincII and
probed by the flanking sequence probe, which was obtained
from the pUC-Ct vector by digesting with BamHI and BglII to
obtain a 0.81-kb fragment. The gene-specific probe (length,
400 bp) was obtained by digesting pLD-SC with BglII and PvuII.
The probes were prepared by random primed 32P-labelling
(Ready-to-go DNA labelling beads, Amersham Pharmacia,
Arlington Heights, IL). The probes were hybridized to the
membrane using Stratagene Quick-hyb solution and protocol,
as described previously (Daniell, 1997; Daniell et al., 2004b;
Kumar and Daniell, 2004). The radiolabelled blots were exposed
to X-ray films and developed in an X-ray film processor.
Western blot analysis
Protein was extracted from 100 mg of plant leaf tissue from
both untransformed and transformed plants, as described
previously (Daniell, 1997; Daniell et al., 2004b; Kumar and
Daniell, 2004). Protein extracts mixed with sample loading
buffer containing BME (beta mercaptoethanol) were boiled
for 5 min and loaded into 10% sodium dodecylsulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) gel. The
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separated proteins were transferred to a membrane and
blocked with P-T-M [phosphate-buffered saline (PBS): 12 mM
Na2HPO4, 3.0 mM NaH2PO4·H2O, 145 mM NaCl, pH 7.2; 0.5%
Tween 20; 3% dry milk], as described previously (Daniell,
1997; Daniell et al., 2004b; Kumar and Daniell, 2004). LecA
was detected by goat anti-LecA antibody, and the secondary
antibody was anti-goat IgG antibody conjugated with
horseradish peroxidase (Sigma, St. Louis, MO, USA).
Estimation of TSP
The Bradford assay was used to determine the total protein
from the plant extracts. Ground leaf tissue (100 mg) from
transformed and untransformed plants was used to extract
proteins. Bovine serum albumin (BSA) standards ranged from
0.05 to 0.5 µg/µL. Plant extracts were diluted 1 : 10 and
1 : 20, and 10 µL of each standard and 10 µL of each plant
dilution were added to the wells of a 96-well microtitre plate
(Cell star, Greiner Bio-one, Stonehouse, UK) in duplicate.
Bradford reagent (Bio-Rad protein assay) was diluted 1 : 4
with distilled water as specified, and 200 µL was added to
each well and assayed as described previously (Daniell, 1997;
Daniell et al., 2004b; Kumar and Daniell, 2004). The absorb-
ance was read at 630 nm. Comparison of the absorbance of
known amounts of BSA with that of the samples was used
to estimate the amount of total protein.
ELISA
The quantification of LecA in the plant crude extract was
performed using ELISA (Daniell, 1997; Daniell et al., 2004b;
Kumar and Daniell, 2004). Transgenic (100 mg, young,
mature, old) and wild-type (young, mature, old) leaf samples
exposed to a regular lighting pattern (16 h light and 8 h dark)
were used. Standards ranging from 100 to 1000 ng/mL were
prepared from purified LecA. Standards and protein samples
(100 µL) were coated on to a 96-well polyvinylchloride micro-
titre plate (Cell star) and assayed as described previously
(Daniell, 1997; Daniell et al., 2004b; Kumar and Daniell, 2004).
Goat anti-LecA primary antibody (provided by Dr Mann,
University of Virginia) and horseradish peroxidase-conjugated
rabbit anti-goat IgG secondary antibody (1 : 5000; American
Qualex, San Clemente, CA) were used.
Immunization of mice with plant-derived lectin 
antigen
Three groups of five female 6–7-week-old BALB/c mice were
injected subcutaneously with plant crude extracts on days 0,
15, 30 and 45. Group 1 mice were injected with lectin (10 µg)-
expressing plant crude extracts together with 50 µL of
alhydrogel adjuvant. Group 2 mice were injected with lectin
(10 µg)-expressing plant crude extracts with no adjuvant.
Group 3 mice were injected with plant crude extracts of wild-
type tobacco. Blood was drawn from the retro-orbital plexus
15 days after the final dose (i.e. on day 60). The blood sam-
ples were stored undisturbed for 2 h at room temperature,
and were then centrifuged at 3000 g for 10 min to extract
the serum.
ELISA to detect anti-LecA IgG antibodies in the serum 
samples
Ninety-six-well microtitre ELISA plates were coated with
100 µL/well of purified Escherichia coli-derived lectin stand-
ard obtained at a concentration of 2.0 µg/mL in PBS, pH 7.4.
The plates were stored overnight at 4 °C. Mouse serum sam-
ples were serially diluted (1 : 100–1 : 20 000). Plates were
incubated with 100 µL of diluted serum samples for 1 h at
37 °C, followed by washing with PBS-Tween. The plates
were then incubated for 1 h at 37 °C with 100 µL of horse-
radish peroxidase-conjugated goat anti-mouse IgG (1 : 5000
dilution of 1 mg/mL stock). TMB (3,3′,5,5′-tetramethyl benzi-
dine; American Qualex) was used as the substrate and the
reaction was stopped by the addition of 50 µL of 2 M sulphuric
acid. The plates were read on a plate reader (Dynex Technol-
ogies, Chantilly, VA) at 450 nm. Titre values were calculated
using a cut-off value equal to an absorbance difference of 0.5
between immunized and non-immunized mice.
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